Indianapolis, IN, United States of America

Peter Ambrose Lander



Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2003-2012

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovations of Peter Ambrose Lander

Introduction

Peter Ambrose Lander is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of dyslipidemia treatment. With a total of 9 patents to his name, Lander's work has had a considerable impact on medical science.

Latest Patents

Lander's latest patents include "Compounds and methods for modulating FXR," which details compounds of formula (I) that are useful for treating dyslipidemia and related diseases. Another significant patent is "Compounds and methods for modulating FX-receptors," which also focuses on compounds and their pharmaceutical compositions for treating similar health issues.

Career Highlights

Lander is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to explore and develop new therapeutic methods that address critical health challenges.

Collaborations

Lander has collaborated with esteemed colleagues, including Michael Gregory Bell and Michael James Genin. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Peter Ambrose Lander's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in treating dyslipidemia and related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…